QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)
QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)
QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)
QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)

Revance Therapeutics (RVNC) Insider Trading & Ownership

$5.70
+0.21 (+3.83%)
(As of 12:51 PM ET)

Revance Therapeutics (NASDAQ:RVNC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$11.27 M
Get RVNC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Revance Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RVNC Insider Buying and Selling by Quarter


Revance Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2023Thomas R. CarperU.S. Congress Member (D-DE)Buy$10.55$1,001 - $15,000
9/5/2023Dwight MoxieSVPSell23,853$17.81$424,821.93  
8/3/2023Mark J FoleyCEOSell26,279$22.57$593,117.03  
7/3/2023Mark J FoleyCEOSell26,279$24.94$655,398.26  
7/3/2023Tobin SchilkeCFOSell1,701$25.04$42,593.04  
6/15/2023Carey Oconnor KolajaDirectorSell2,500$28.24$70,600.00  
6/9/2023Dustin S SjutsPresidentSell5,000$30.82$154,100.00  
6/9/2023Mark J FoleyCEOSell31,279$30.72$960,890.88  
6/1/2023Tobin SchilkeCFOSell2,701$30.57$82,569.57  
5/15/2023Dustin S SjutsPresidentSell21,015$34.55$726,068.25  
5/15/2023Dwight MoxieSVPSell21,401$34.55$739,404.55  
5/15/2023Mark J FoleyCEOSell70,447$34.55$2,433,943.85  
5/1/2023Tobin SchilkeCFOSell3,201$31.70$101,471.70  
4/3/2023Tobin SchilkeCFOSell3,201$32.15$102,912.15  
3/9/2023Dustin S SjutsPresidentSell21,508$31.59$679,437.72  
3/9/2023Dwight MoxieSVPSell18,496$31.59$584,288.64  
3/9/2023Mark J FoleyCEOSell70,390$31.59$2,223,620.10  
3/9/2023Tobin SchilkeCFOSell18,517$31.59$584,952.03  
3/1/2023Tobin SchilkeCFOSell3,201$33.50$107,233.50  
(Data available from 1/1/2013 forward)












RVNC Insider Trading Activity - Frequently Asked Questions

Who is on Revance Therapeutics's Insider Roster?

The list of insiders at Revance Therapeutics includes Angus C Russell, Aubrey Rankin, Carey Oconnor Kolaja, Dustin S Sjuts, Dwight Moxie, Mark J Foley, and Tobin Schilke. Learn more on insiders at RVNC.

What percentage of Revance Therapeutics stock is owned by insiders?

3.60% of Revance Therapeutics stock is owned by insiders. Learn more on RVNC's insider holdings.

Which Revance Therapeutics insiders have been selling company stock?

The following insiders have sold RVNC shares in the last 24 months: Carey Oconnor Kolaja ($70,600.00), Dustin S Sjuts ($1,559,605.97), Dwight Moxie ($2,046,285.12), Mark J Foley ($6,866,970.12), and Tobin Schilke ($1,264,005.75).

How much insider selling is happening at Revance Therapeutics?

Insiders have sold a total of 389,871 Revance Therapeutics shares in the last 24 months for a total of $11,807,466.96 sold.

Which members of congress are trading Revance Therapeutics?

Thomas R. Carper (D-DE) has bought shares of Revance Therapeutics in the last year totaling $8,000.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:RVNC) was last updated on 2/26/2024 by MarketBeat.com Staff